Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Benefits"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"140 - Specific philosophical schools"
dewey-ones:"330 - Economics"
language:"English"
Showing
1
-
20
of
36
Search:
'"Benefits"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
2
Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
3
Effect of oseltamivir (TamifluR) for the prevention and treatment of influenza during an influenza pandemic
by
Mørland, Berit
Published 2005
Norwegian Knowledge Centre for the Health Services
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
4
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
5
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
6
Management Challenges for Business in Digital Economy: New Pathways and Research Trends
by
Korsakienė, Renata
Published 2023
MDPI - Multidisciplinary Digital Publishing Institute
Subjects:
“
...relational
benefits
...
”
Read Now
7
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2017
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
8
Pharmacoeconomic review report: Sarilumab (Kevzara)
Published 2017
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
11
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
12
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
13
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication: for the treatment of adult patients with active ankylosing spondylitis who have responded i...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
14
High dose influenza vaccine for adults : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Wells, Charlotte
,
Grobelna, Aleksandra
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
15
High dose influenza vaccine for adults : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Wells, Charlotte
,
Grobelna, Aleksandra
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
16
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
17
Pharmacoeconomic review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication: indicated in addition to standard therapy for reducing disease activity in adult patients...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.) : indication: systemic lupus erythematosus (SLE)
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
19
Pharmacoeconomic report: Vedolizumab (Entyvio SC) Takeda Canada Inc. : indication : for the treatment of adult patients with moderately to severely active ulcerative colitis who ha...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 140 - Specific philosophical schools
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
330 - Economics
610 - Medicine & health
17
700 - The arts; fine & decorative arts
13
000 - Computer science, information & general works
9
363 - Other social problems & services
9
more ...
333 - Economics of land & energy
8
380 - Commerce, communications & transportation
6
320 - Political science
5
600 - Technology
5
551 - Geology, hydrology & meteorology
4
581 - Specific topics in natural history
4
800 - Literature & rhetoric
4
370 - Education
3
576 - Genetics & evolution
3
580 - Plants (Botany)
3
657 - Accounting
3
620 - Engineering & allied operations
2
900 - History & geography
2
170 - Ethics
1
200 - Religion
1
297 - Islam, Babism & Bahai Faith
1
300 - Social sciences
1
304 - Factors affecting social behavior
1
340 - Law
1
361 - Social problems & social welfare in general
1
414 - Phonology & phonetics
1
630 - Agriculture & related technologies
1
658 - General management
1
see all ...
less ...
Language
English
Collection
National Center for Biotechnology Information
22
Directory of Open Access Books
14
Author
Canadian Agency for Drugs and Technologies in Health
19
CADTH Canadian Drug Expert Committee
7
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
4
Campbell, Kaitryn
2
Es-Safi, Nour Eddine
2
Grobelna, Aleksandra
2
more ...
Wells, Charlotte
2
Young, Calvin
2
Azevedo, Susana Garrido
1
Chen, Jie
1
Cirella, Giuseppe T.
1
Gómez, Víctor Alonso
1
Hashemi, Shervin
1
Hernández-Callejo, Luis
1
Jesevičiūtė-Ufartienė, Laima
1
Korsakienė, Renata
1
Leite, Vicente
1
Li, Hongxia
1
Matias, João Carlos de Oliveira
1
Mørland, Berit
1
Napolitano, Fabio
1
Nasjonalt kunnskapssenter for helsetjenesten
1
Nesmachnow, Sergio
1
Núñez-Delgado, Avelino
1
Pallante, Giacomo
1
Pimentel, Carina
1
Reggiani, Paolo
1
Russo, Alessio
1
Salvatori, Elisabetta
1
Vilkaitė-Vaitonė, Neringa
1
Yigitcanlar, Tan
1
Zhang, Ting
1
Zhang, Wenxiang
1
Zhang, Yongqiang
1
Zhang, Zhien
1
Zhou, Qian
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Benefits%22&type=Subject
Send by Email
×
Loading...